Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 4,480 shares at $259.91 ($1.2M) on 2024-05-03, disclosed to the SEC on 2024-05-06.
Seasonal sale ($1.2M) by Director — this insider has traded UTHR in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $259.91 | 2,240 | $582K | 50.0% |
| 2 | $259.91 | 2,240 | $582K | 50.0% |
| Total | $259.91 avg | 4,480 | $1.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |